Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-18-007424
Filing Date
2018-09-10
Accepted
2018-09-10 16:06:00
Documents
5
Effectiveness Date
2018-09-10

Document Format Files

Seq Description Document Type Size
1 S-8 s-8.htm S-8 210008
2 EX-5.01 ex-5d01.htm EX-5.01 22589
3 EX-23.2 ex-23d2.htm EX-23.2 5944
4 EX-99.1 ex-99d1.htm EX-99.1 161937
5 GRAPHIC ex-5d01g001.jpg GRAPHIC 39376
  Complete submission text file 0001558370-18-007424.txt   455798
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: S-8 | Act: 33 | File No.: 333-227262 | Film No.: 181062807
SIC: 2834 Pharmaceutical Preparations